SCHEMBL16709205

SCHEMBL16709205

O=C([C@H]1CC[C@@H](CO)CC1)N(CCN1CCN(c2ccccc2)CC1)c1ccccn1

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 11/20 0.80
DRD4 P21917 8/20 0.80
ADRA1A P35348 6/20 0.80
ADRA1B P35368 5/20 0.80
HTR7 P34969 3/20 0.80
HTR2B P41595 3/20 0.80
HTR2A P28223 2/20 0.80
SMN1; SMN2 Q16637 2/20 0.64
OPRM1 P35372 2/20 0.59
ADRA1D P25100 3/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
TSHR P16473 1/20 0.58
HTR1B P28222 1/20 0.58
MEN1 O00255 1/20 0.56
LMNA P02545 1/20 0.56
BLM P54132 1/20 0.56
PMP22 Q01453 1/20 0.56
KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16709196 1.00 HTR1A (0.80) HTR1ADRD4ADRA1AADRA1BHTR7
SCHEMBL16709200 1.00 HTR1A (0.80) HTR1ADRD4ADRA1AADRA1BHTR7
SCHEMBL16709199 0.91 HTR1A (0.85) HTR1ADRD4ADRA1AADRA1BHTR7
SCHEMBL16709197 0.91 HTR1A (0.85) HTR1ADRD4ADRA1AADRA1BHTR7
SCHEMBL16709198 0.91 HTR1A (0.85) HTR1ADRD4ADRA1AADRA1BHTR7
SCHEMBL8010894 0.89 HTR1A (1.00) HTR1ADRD4ADRA1AADRA1BHTR7
SCHEMBL16709202 0.87 HTR1A (0.77) HTR1ADRD4ADRA1AADRA1BHTR7
SCHEMBL12677610 0.85 HTR1A (0.86) HTR1ADRD4ADRA1AADRA1BHTR7
SCHEMBL12677609 0.85 HTR1A (0.86) HTR1ADRD4ADRA1AADRA1BHTR7
SCHEMBL9605402 0.85 HTR1A (0.86) HTR1ADRD4ADRA1AADRA1BHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150133663-A1 NOVEL SYNTHESIS METHOD GE HEALTHCARE LIMITED (GB) 2015-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150133663-A1 NOVEL SYNTHESIS METHOD HTR1A, HTR5A, TPH1 HTR1A 1/4885DRD4 41/4885ADRA1A 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.